Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAGM.L Regulatory News (AGM)

  • There is currently no data for AGM

AGM Statement

18 Dec 2018 07:00

RNS Number : 7418K
Applied Graphene Materials PLC
18 December 2018
 

18 December 2018

 

Applied Graphene Materials plc

 

("Applied Graphene Materials", "the Group" or "the Company")

 

Annual General Meeting Statement

 

Key milestone achieved with James Briggs Ltd order

 

Applied Graphene Materials, the producer of specialty graphene materials, will be holding its Annual General Meeting at 11.00am today at The Farndale Suite, The Wilton Centre, Redcar, Cleveland, TS10 4RF, during which the Chairman, Bryan Dobson, will make the following statement: 

"The Board continues to focus on the commercialisation of its products and proprietary technologies via its numerous active engagements and has made good progress in recent months.

I am pleased to report that we have recently achieved a key milestone, having fulfilled the scale-up production purchase order from James Briggs Ltd (JBL) in preparation for full product launch. JBL has successfully completed its first production batch which is a significant milestone for commercial realisation. Extensive testing has demonstrated repeated and outstanding improvements in anti-corrosion performance for JBL's automotive aerosol primer. JBL plans to launch their new range of graphene enhanced anti-corrosion aerosols under their Hycote brand.

We were also pleased to participate in the opening of the UK's Graphene Engineering and Innovation Centre (GEIC) in Manchester last week. Meeting with multiple participants, the opportunities for graphene technology remain buoyant. Finding practical application solutions for the challenges surrounding the exploitation of graphene nanoplatelet technology is the key focus of AGM's strategy for commercial progress and this is wholly complementary to the objectives of GEIC. We look forward to working closely with GEIC in the months ahead in the further development of world-class application solutions. 

We have had significant changes on the Executive team in the last few months and Adrian and David have both settled into their new roles very quickly as Chief Executive and Chief Financial Officer. Their absolute focus is to increase the commercial momentum and to grow the business and revenues.

The Group continues to be well funded as it seeks to capitalise on the ever maturing pipeline of opportunities."

 

For further information, please contact:

 

Applied Graphene Materials +44 (0) 1642 438 214

Adrian Potts, Chief Executive Officer

David Blain, Chief Financial Officer

 

N+1 Singer +44 (0) 207 496 3000

Richard Lindley / Justin McKeegan

 

Hudson Sandler +44 (0) 207 796 4133

Charlie Jack / Emily Dillon

Notes to Editors

Applied Graphene Materials works in partnership with its customers using its knowledge and expertise to provide bespoke graphene dispersions and formats to deliver enhancements and benefits for a wide range of applications. The Group's strategy is to target commercial applications in three core markets: coatings, composites and functional materials. 

The Group has developed proprietary bottom-up processes which are capable of producing high purity graphene nanoplatelets using a continuous process. The manufacturing process is based on sustainable, readily available raw materials and therefore does not rely on the supply of graphite, unlike a number of other graphene production techniques. Applied Graphene Materials owns the intellectual property and know-how behind this process.

Applied Graphene Materials was founded by Professor Karl Coleman in 2010 with its operations and processes based on technology that he initially developed at Durham University. The Group was admitted to AIM in November 2013, raising £11 million, and is based at the Wilton Site on Teesside. In January 2016 the Group raised £8.5m to support its ongoing activities and in October 2017 the Group raised a further £9.8m.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMEAKAXFSKPFFF
Date   Source Headline
14th Oct 20209:05 amRNSSecond Price Monitoring Extn
14th Oct 20209:00 amRNSPrice Monitoring Extension
14th Oct 20207:00 amRNSFull Year Results
8th Oct 20207:00 amRNSLaunch of Commercial R&D Partnership Service
7th Oct 20202:00 pmRNSPrice Monitoring Extension
6th Oct 20207:00 amRNSNotice of Results
2nd Oct 20204:41 pmRNSSecond Price Monitoring Extn
2nd Oct 20204:36 pmRNSPrice Monitoring Extension
23rd Sep 20202:05 pmRNSSecond Price Monitoring Extn
23rd Sep 20202:00 pmRNSPrice Monitoring Extension
23rd Sep 202011:00 amRNSPrice Monitoring Extension
23rd Sep 20209:05 amRNSSecond Price Monitoring Extn
23rd Sep 20209:00 amRNSPrice Monitoring Extension
23rd Sep 20207:00 amRNSCustomer product launched in car care market
15th Sep 20204:40 pmRNSSecond Price Monitoring Extn
15th Sep 20204:35 pmRNSPrice Monitoring Extension
10th Sep 20202:00 pmRNSPrice Monitoring Extension
9th Sep 20204:41 pmRNSSecond Price Monitoring Extn
9th Sep 20204:35 pmRNSPrice Monitoring Extension
9th Sep 20202:05 pmRNSSecond Price Monitoring Extn
9th Sep 20202:00 pmRNSPrice Monitoring Extension
3rd Sep 202011:41 amRNSExercise of Options
3rd Sep 202011:05 amRNSSecond Price Monitoring Extn
3rd Sep 202011:00 amRNSPrice Monitoring Extension
20th Aug 20202:05 pmRNSSecond Price Monitoring Extn
20th Aug 20202:00 pmRNSPrice Monitoring Extension
12th Aug 20202:00 pmRNScommences trading on the OTCQB Venture Market
4th Aug 20207:00 amRNSAGM signs distribution agreement with Arpadis
3rd Aug 20207:00 amRNSAGM signs distribution agreement with Maroon Group
27th Jul 20202:00 pmRNSSignature of distribution agreement
6th Jul 20202:05 pmRNSSecond Price Monitoring Extn
6th Jul 20202:00 pmRNSPrice Monitoring Extension
6th Jul 202011:05 amRNSSecond Price Monitoring Extn
6th Jul 202011:00 amRNSPrice Monitoring Extension
24th Jun 20202:55 pmRNSHolding(s) in Company
24th Jun 20202:39 pmRNSHolding(s) in Company
23rd Jun 202011:06 amRNSSecond Price Monitoring Extn
23rd Jun 202011:00 amRNSPrice Monitoring Extension
16th Jun 20209:05 amRNSSecond Price Monitoring Extn
16th Jun 20209:00 amRNSPrice Monitoring Extension
11th Jun 20209:05 amRNSSecond Price Monitoring Extn
11th Jun 20209:00 amRNSPrice Monitoring Extension
5th Jun 20207:00 amRNSSignature of distribution agreement
25th Mar 20207:00 amRNSInterim Results
24th Mar 20202:48 pmRNSHolding(s) in Company
23rd Mar 20204:42 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:38 pmRNSPrice Monitoring Extension
16th Mar 20208:54 amRNSNotice of Interim Results
6th Feb 20207:00 amRNSAGM to present at international conferences
17th Dec 20193:00 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.